Female patients with small cell lung cancer live longer than male patients

The American Journal of Medicine

Volumn 85, Issue 2, 1988, Pages 194-196

  Johnson, Bruce E ^a,b   Steinberg, Seth M ^a,b   Phelps, Ruby ^a,b   Edison, Margaret ^a,b   Veach, Stephen R ^a,b   Ihde, Daniel C ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEX; SEX DIFFERENCE; SURVIVAL;

CARCINOMA, SMALL CELL; FEMALE; HUMAN; LUNG NEOPLASMS; MALE; SEX FACTORS; TIME FACTORS;

EID: 0023765698     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(88)80341-3     Document Type: Article

References (19)

1. Cancer statistics
2. Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung
3. Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation
4. Long-term disease-free survival in small cell carcinoma of the lung: a study of clinical determinants
5. Prognostic factors in small cell carcinoma of the lung: a cancer and leukemia group B study
6. Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy
7. The clinical behavior of “mixed” small cell/large cell bronchogenic carcinoma compared to “pure” small cell subtypes
8. Late intensive combined modality therapy followed by autologous bone marrow infusion in extensivestage smallcell lung cancer
9. Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer: a prospective, randomized trial
10. Treatment of extensive stage small cell bronchogenic carcinoma. Effects of variation in intensity of induction chemotherapy
11. Randomized trial of high dose versus standard dose etoposide and cisplatin (VP-16/plat) in extensive stage small cell lung cancer (SCLC) (abstr)
12. Non-parametric estimation from incomplete observations
13. Evaluation of survival data and two new rank order statistics arising in its consideration
14. Regression models lifetables
15. Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-smallcelllung cancer treated with combination chemotherapy
16. A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer
17. Longterm survivors in metastatic nonsmallcell lung cancer. An Eastern Cooperative Oncology Group Study
18. Cutaneous melanoma
19. Acute lympoid leukemia